Skip to main content

Peer Review reports

From: Meta-analysis and indirect treatment comparison of modified FOLFIRINOX and gemcitabine plus nab-paclitaxel as first-line chemotherapy in advanced pancreatic cancer

Original Submission
1 Jun 2020 Submitted Original manuscript
5 Jun 2020 Author responded Author comments - Jiayuan Chen
Resubmission - Version 2
5 Jun 2020 Submitted Manuscript version 2
12 Jun 2020 Author responded Author comments - Jiayuan Chen
Resubmission - Version 3
12 Jun 2020 Submitted Manuscript version 3
26 Aug 2020 Reviewed Reviewer Report
2 Apr 2021 Reviewed Reviewer Report
4 May 2021 Author responded Author comments - Jiayuan Chen
Resubmission - Version 4
4 May 2021 Submitted Manuscript version 4
10 May 2021 Reviewed Reviewer Report
17 May 2021 Reviewed Reviewer Report
22 May 2021 Author responded Author comments - Jiayuan Chen
Resubmission - Version 5
22 May 2021 Submitted Manuscript version 5
28 May 2021 Reviewed Reviewer Report
2 Jul 2021 Author responded Author comments - Jiayuan Chen
Resubmission - Version 6
2 Jul 2021 Submitted Manuscript version 6
Publishing
16 Jul 2021 Editorially accepted
23 Jul 2021 Article published 10.1186/s12885-021-08605-x

You can find further information about peer review here.

Back to article page